Cleared Traditional

K200277 - Livongo Blood Glucose Monitoring System (BG1000)

K200277 is an FDA 510(k) clearance for Livongo Blood Glucose Monitoring System..., manufactured by Livongo Health, Inc.. The device is a Class 2 Chemistry device with product code NBW cleared through the Traditional 510(k) pathway after a 121-day FDA review.

K200277 · Livongo Health, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
121d
Days
Class 2
Risk

K200277 is an FDA 510(k) clearance for the Livongo Blood Glucose Monitoring System (BG1000). Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Livongo Health, Inc. (Mountain View, US). The FDA issued a Cleared decision on June 4, 2020 after a review of 121 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Livongo Health, Inc. devices

FDA 510(k) Submission Details - K200277

510(k) Number K200277 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2020
Decision Date June 04, 2020
Days to Decision 121 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d slower than avg
Panel avg: 88d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 420
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K200277.
Finetest Lite Blood Glucose Monitoring System
K203562 · Osang Healthcare Co. , Ltd. · Jul 2021
Finetest Lite Smart Blood Glucose Monitoring System
K201396 · Osang Healthcare Co. , Ltd. · Oct 2020
GoChek Blood Glucose Monitoring System, GoChek Connect Blood Glucose Monitoring System
K193340 · Microtech Medical, Inc. · Sep 2020
Bioland Blood Glucose Monitoring System
K191657 · Bioland Technology, Ltd. · Mar 2020
OneTouch Verio Reflect Blood Glucose Monitoring System
K193475 · Lifescan Europe GmbH · Feb 2020
CareSens S Clear BT Blood Glucose Monitoring System
K192859 · I-Sens, Inc. · Jan 2020